Quality of life in patients with progressive keratoconus treated with corneal collagen crosslinking
International Ophthalmology · 2025
DOI: 10.1007/s10792-024-03400-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Ophthalmology, 2025. Verfasst von J Steinberg und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. steinberg@hamburgvisionclinic.com. Hauptthemen laut MEDLINE: Keratoconus, Quality of Life, Cross-Linking Reagents, Collagen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Hamburg-Eppendorf (UKE).
Abstract (Originalsprache)
Purpose
This study aims to analyze the vision-related quality of life (vr-QoL) in keratoconus (KC) patients after corneal crosslinking (CXL).
Methods
A prospective clinical study was conducted, wherein 41 patients underwent assessment using the "National Eye Institute Visual Functioning Questionnaire" (NEI-25) and the "Keratoconus Outcomes Research Questionnaire" (KORQ) to evaluate vr-QoL, along with the examination of morphology and functional parameters before CXL, and at three and six months post-treatment. Rasch analyses were used to verify the measurement precision of the KORQ with our study population.
Results
There were no statistically significant changes observed in corneal morphology and best corrected visual acuity after CXL. Analysis of the NEI-25 questionnaires and KORQ demonstrated no statistically significant changes throughout the follow-up period. Rasch analyses revealed a high measurement precision of the KORQ within our population.
Conclusion
The study indicates that patients with progressive KC maintain stable vr-QoL after undergoing CXL. Based on our findings, we suggest considering very early CXL treatment for KC patients that are at high risk of progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. steinberg@hamburgvisionclinic.com.
- Medical and Research Center for Ophthalmology, Hamburg Vision Clinic, Hamburg, Germany. steinberg@hamburgvisionclinic.com.
- Hamburg Vision Clinic / Zentrumsehstärke, Campus of the University Hospital Hamburg - Eppendorf (UKE), Martinistrasse 64, 20251, Hamburg, Germany. steinberg@hamburgvisionclinic.com.
- Department of Ophthalmology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Department of Ophthalmology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
- Medical and Research Center for Ophthalmology, Hamburg Vision Clinic, Hamburg, Germany.
Förderung
- Universitätsklinikum Hamburg-Eppendorf (UKE)
Zitieren
APA
Steinberg, J., Fischer, P., Frings, A., Druchkiv, V., Katz, T., & Linke, S. J. (2025). Quality of life in patients with progressive keratoconus treated with corneal collagen crosslinking. International Ophthalmology. https://doi.org/10.1007/s10792-024-03400-6
Vancouver
Steinberg J, Fischer P, Frings A, Druchkiv V, Katz T, Linke SJ. Quality of life in patients with progressive keratoconus treated with corneal collagen crosslinking. International Ophthalmology. 2025. doi:10.1007/s10792-024-03400-6
BibTeX
@article{Steinberg2025,
author = {Steinberg, J and Fischer, P and Frings, A and Druchkiv, V and Katz, T and Linke, S J},
title = {Quality of life in patients with progressive keratoconus treated with corneal collagen crosslinking},
journal = {International Ophthalmology},
year = {2025},
doi = {10.1007/s10792-024-03400-6}
}
EUVIMED